- İstanbul Journal of Pharmacy
- Volume:50 Issue:1
- Development and validation of an HPLC method for determination of carbamazepine in human plasma and ...
Development and validation of an HPLC method for determination of carbamazepine in human plasma and applications to a therapeutic drug monitoring study
Authors : Emrah DURAL, Süleyman ÇETİN, Aslı BOLAYIR, Burhanettin ÇİĞDEM
Pages : 6-15
View : 46 | Download : 14
Publication Date : 2020-04-01
Article Type : Research Paper
Abstract :Background and Aims: Carbamazepine insert ignore into journalissuearticles values(CBZ); is an antiepileptic drug, which is prescribed as a first-line drug for the treatment of partial and generalized tonic–clonic epileptic seizures. The aim of this study was to develop and validate a simple, fast and reliable HPLC method for the determination of carbamazepine in human plasma. Methods: Chlorpromazine insert ignore into journalissuearticles values(CPR); was used as an internal standard. The separation was conducted with a C18 reverse-phase column insert ignore into journalissuearticles values(150x3.9 mm, 5 µm); at 30°C, using a mobile phase prepared with 20 mM KH2PO4, acetonitrile and methanol insert ignore into journalissuearticles values(6:3:1, v/v/v); by isocratic elution. Results: The method was linear between 0.5 and 40 µg/mL, determined by 10 individual calibration points. Total run time was ≤ 5 mins. Accuracy insert ignore into journalissuearticles values(RE%); values were determined between insert ignore into journalissuearticles values(-5.6); and 3.6%, and precision was determined at ≤4.2%. Limit of detection insert ignore into journalissuearticles values(LOD); was 0.04 µg/mL. The robustness test results of the method showed good values. Plasma CBZ of insert ignore into journalissuearticles values(n=30); those receiving CBZ quantities ranging from 0.2 to 1.2 g/day were measured with this method, and following analyses of their concentrations were found to be between 0.1 and 11.4 µg/mL insert ignore into journalissuearticles values(6.2±2.4 µg/mL);. While all plasma sample analyses were applied properly, it was observed that 16 insert ignore into journalissuearticles values(53.3%); of the plasma samples had CBZ lower than the recommended range. In addition to that, female patient plasma-CBZ levels were found significantly higher than male plasma contents insert ignore into journalissuearticles values(p<0.05);. Conclusion: This method was found suitable for the analysis of plasma samples collected during the therapeutic drug monitoring insert ignore into journalissuearticles values(TDM); of patients treated with CBZ.Keywords : Carbamazepine, plasma, therapeutic drug monitoring, high performance liquid chromatography, ultraviolet detection
ORIGINAL ARTICLE URL
